We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
On 3 September 2010, the Competition Committee of the Organization for Economic Cooperation and Development (OECD) published a summary of its October 2009 roundtable discussion on generic pharmaceuticals
While the insurance industry in the United States has been the subject of considerable antitrust attention recently, there has been a marked increase in antitrust regulator scrutiny of insurer practices outside the United States as well
